Matches in SemOpenAlex for { <https://semopenalex.org/work/W2415104003> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2415104003 endingPage "94" @default.
- W2415104003 startingPage "187" @default.
- W2415104003 abstract "The prognosis of Stage III unresectable non-small cell lung cancer may be improved by concurrent chemoradiotherapy. In this study, we attempted to evaluate the feasibility, tolerance, efficacy and toxicities of the combination of thoracic radiation and chemotherapy with a novel regimen that included 5-fluorouracil, leucovorin, etoposide and cisplatin (the FLEP regimen) in the treatment of this group of patients.From July 1995 to September 1996, 20 untreated patients with locally advanced non-small cell lung cancer were enrolled in the study. Radiation at a dose of 44 Gy was initially delivered in daily fractions of 2 Gy 5 days a week to the tumor and mediastinum, followed by a boost to the tumor (20 to 26 Gy according to patients tolerance). Concurrently with thoracic irradiation, patients were treated with chemotherapy consisting of cisplatin at the dose of 60 mg/m2/d for 1 day, etoposide at the dose of 60 mg/m2/d for 2 days, and 5-FU 500 mg/m2/d plus leucovorin 50 mg/d infusion for 48 hours. Cycles of chemotherapy were repeated every 3 weeks for a maximum of 3 cycles.Seventeen of 20 patients were assessable. The overall response rate was 70.6% (95% confidence interval = 49-92%). No complete response was achieved. The median response duration for all responding patients is not yet estimable, with a range of 3.5 to 15.5+ months. Eleven patients remain progression-free for 4 to 15 months. The median survival for the entire group is not estimable. The major toxicity was esophagitis. Other grade 3 or 4 toxicities were not frequently observed.Combined-modality therapy with FLEP regimen and radiation is a promising treatment with a high response rate and acceptable toxicity for locally advanced non-small cell lung cancer." @default.
- W2415104003 created "2016-06-24" @default.
- W2415104003 creator A5010925591 @default.
- W2415104003 creator A5016616222 @default.
- W2415104003 creator A5073474387 @default.
- W2415104003 creator A5084457104 @default.
- W2415104003 creator A5086519541 @default.
- W2415104003 creator A5089505089 @default.
- W2415104003 date "1997-09-01" @default.
- W2415104003 modified "2023-09-23" @default.
- W2415104003 title "Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer." @default.
- W2415104003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9397609" @default.
- W2415104003 hasPublicationYear "1997" @default.
- W2415104003 type Work @default.
- W2415104003 sameAs 2415104003 @default.
- W2415104003 citedByCount "1" @default.
- W2415104003 crossrefType "journal-article" @default.
- W2415104003 hasAuthorship W2415104003A5010925591 @default.
- W2415104003 hasAuthorship W2415104003A5016616222 @default.
- W2415104003 hasAuthorship W2415104003A5073474387 @default.
- W2415104003 hasAuthorship W2415104003A5084457104 @default.
- W2415104003 hasAuthorship W2415104003A5086519541 @default.
- W2415104003 hasAuthorship W2415104003A5089505089 @default.
- W2415104003 hasConcept C126322002 @default.
- W2415104003 hasConcept C126894567 @default.
- W2415104003 hasConcept C141071460 @default.
- W2415104003 hasConcept C2776256026 @default.
- W2415104003 hasConcept C2776694085 @default.
- W2415104003 hasConcept C2778119113 @default.
- W2415104003 hasConcept C2778239845 @default.
- W2415104003 hasConcept C2778424827 @default.
- W2415104003 hasConcept C2779562246 @default.
- W2415104003 hasConcept C2780456651 @default.
- W2415104003 hasConcept C2781413609 @default.
- W2415104003 hasConcept C45393284 @default.
- W2415104003 hasConcept C500558357 @default.
- W2415104003 hasConcept C509974204 @default.
- W2415104003 hasConcept C71924100 @default.
- W2415104003 hasConcept C90924648 @default.
- W2415104003 hasConceptScore W2415104003C126322002 @default.
- W2415104003 hasConceptScore W2415104003C126894567 @default.
- W2415104003 hasConceptScore W2415104003C141071460 @default.
- W2415104003 hasConceptScore W2415104003C2776256026 @default.
- W2415104003 hasConceptScore W2415104003C2776694085 @default.
- W2415104003 hasConceptScore W2415104003C2778119113 @default.
- W2415104003 hasConceptScore W2415104003C2778239845 @default.
- W2415104003 hasConceptScore W2415104003C2778424827 @default.
- W2415104003 hasConceptScore W2415104003C2779562246 @default.
- W2415104003 hasConceptScore W2415104003C2780456651 @default.
- W2415104003 hasConceptScore W2415104003C2781413609 @default.
- W2415104003 hasConceptScore W2415104003C45393284 @default.
- W2415104003 hasConceptScore W2415104003C500558357 @default.
- W2415104003 hasConceptScore W2415104003C509974204 @default.
- W2415104003 hasConceptScore W2415104003C71924100 @default.
- W2415104003 hasConceptScore W2415104003C90924648 @default.
- W2415104003 hasIssue "3" @default.
- W2415104003 hasLocation W24151040031 @default.
- W2415104003 hasOpenAccess W2415104003 @default.
- W2415104003 hasPrimaryLocation W24151040031 @default.
- W2415104003 hasRelatedWork W1990897966 @default.
- W2415104003 hasRelatedWork W2033874026 @default.
- W2415104003 hasRelatedWork W2087536441 @default.
- W2415104003 hasRelatedWork W2349270370 @default.
- W2415104003 hasRelatedWork W2359366932 @default.
- W2415104003 hasRelatedWork W2360929566 @default.
- W2415104003 hasRelatedWork W2389384568 @default.
- W2415104003 hasRelatedWork W3132947760 @default.
- W2415104003 hasRelatedWork W802126212 @default.
- W2415104003 hasRelatedWork W88184138 @default.
- W2415104003 hasVolume "20" @default.
- W2415104003 isParatext "false" @default.
- W2415104003 isRetracted "false" @default.
- W2415104003 magId "2415104003" @default.
- W2415104003 workType "article" @default.